Development of probiotic products for nutritional requirements of specific human populations

Engineering in Life Sciences

Volumn 12, Issue 4, 2012, Pages 368-376

  Arboleya, Silvia ^a   González, Sonia ^b   Salazar, Nuria ^a   Ruas Madiedo, Patricia ^a   de los Reyes Gavilán, Clara G ^a   Gueimonde, Miguel ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Elderly; Gut microbiota; Infants; Probiotics

Indexed keywords

BENEFICIAL EFFECTS; ELDERLY; FOOD INDUSTRIES; FUNCTIONAL FOODS; GENERAL POPULATION; HEALTH BENEFITS; HUMAN POPULATION; HUMAN STUDY; IMMUNE MODULATION; INFANTS; JOINT DEVELOPMENT; MICROBIOTAS; PROBIOTIC PRODUCTS; PROBIOTICS;

BIOLOGY; BIOTECHNOLOGY;

FOOD MICROBIOLOGY;

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; CORTICOSTEROID; FOLIC ACID; IRON; MAGNESIUM; OMEGA 3 FATTY ACID; PROBIOTIC AGENT; PYRIDOXINE; RETINOL; RIBOFLAVIN; SELENIUM; SHORT CHAIN FATTY ACID; VITAMIN D; ZINC;

DIGESTIVE SYSTEM; ELDERLY POPULATION; FOOD INDUSTRY; FOOD MARKET; FOOD PROCESSING; IMMUNE SYSTEM; NEONATE; NUTRITIONAL REQUIREMENT; PROBIOTICS; PUBLIC HEALTH;

ABDOMINAL PAIN; AGING; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM; BLOATING; BRAIN INJURY; BREAST FEEDING; BREAST MILK; CELIAC DISEASE; CHRONIC LUNG DISEASE; COLITIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROHN DISEASE; DEFECATION HABIT; FOOD ALLERGY; GLUTEN FREE DIET; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; INTESTINE INFECTION; LACTOBACILLUS RHAMNOSUS; META ANALYSIS; MICROFLORA; NECROTIZING ENTEROCOLITIS; NUTRITIONAL INTOLERANCE; NUTRITIONAL REQUIREMENT; OXIDATIVE STRESS; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STOMACH ACID SECRETION; TH2 CELL; ULCERATIVE COLITIS; VITAMIN SUPPLEMENTATION;

EID: 84865540564     PISSN: 16180240     EISSN: 16182863     Source Type: Journal    
DOI: 10.1002/elsc.201100129     Document Type: Review

References (91)

1. FAO/WHO. FAO Food and Nutrition paper 85. 2006. FAO, Rome, Italy.
2. Wallace, T. C., Guarner, F., Madsen, K., Cabana, M. D. et al., Human gut microbiota and its relationship to health and disease. Nutr. Rev. 2011, 69, 392-403.
3. Floch, M. H., Walker, W. A., Madsen, K., Sanders, M. E. et al., Recommendations for probiotic use-2011 Update. J. Clin. Gastroenterol. 2011, 45(Suppl 3), S168-S171.
4. O'Toole, P. W., Claesson, M. J., Gut microbiota: changes throughout the lifespan from infancy to elderly. Int. Dairy J. 2010, 20, 281-291.
5. Hooper, L. V., Macpherson, A. J., Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 2010, 10, 159-169.
6. Thomas, D. W., Greer, F. R., Probiotics and prebiotics in pediatrics. Pediatrics. 2010, 126, 1217-1231.
7. Jacquot, A., Neveu, D., Aujoulat, F., Mercier, G. et al., Dinamics and clinical evolution of bacterial gut microflora in extremely premature babies. J. Pediatr. 2011, 158, 390-396.
8. Arboleya, S., Binetti, A., Salazar, N., Fernández, N. et al., Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol. Ecol. 2012, 79, 763-772.
9. Millar, M., Wilks, M., Costeloe, K., Probiotics for premature infants? Arch. Dis. Child Fetal Neonatal. 2003, 88, 354-358.
10. Anand, R. J., Leaphart, C. L., Mollen, K. P., Hackam, D. J., The role of the intestinal barrier in the pathogenesis of necrotizing enterocolitis. Shock 2007, 27, 124-133.
11. Afrazi, A., Sodhi, C. P., Richardson, W., Neal, M. et al., New insights into the pathogenesis and treatment of necrotizing enterocolitis: toll-like receptors and beyond. Pediatr. Res. 2011, 69, 183-188.
12. Emami, C. N., Petrosyan, M., Giuliani, S., Williams, M. et al., Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis. Surg. Infect .(Larchmt). 2009, 10, 407-417.
13. Deshpande, G. C., Rao, S. C., Keil, A. D., Patole, S. K., Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med. 2011, 9, 92.
14. Hunter, C. J., Upperman, J. S., Ford, H., Camerini, V., Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr. Res. 2008, 63, 117-123.
15. Stenger, M. R., Reber, K. M., Giannone, P. J., Nankervis, C. A., Probiotics and probiotics for the prevention of necrotizing enterocolitis. Curr. Infect. Dis. Rep. 2011, 13, 13-20.
16. Manzoni, P., Rizzollo, S., Vain, N., Mostert, M. et al., Probiotics use in preterm neonates: what further evidence is needed? Early Hum. Dev. 2011, 87(Suppl 1), S3-S4.
17. Harmsen, H. J. M., Wildeboer-Veloo, A. C. M., Raangs, G. C., Wagendorp, A. A. et al., Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatric. Gastroenterol. Nutr. 2000, 30, 61-67.
18. Huërou-Luron, I. L., Blat, S., Boudry, G., Breast- vs formula-feeding: impacts on the digestive tract and immediate and long-term health effect. Nutr. Res. Rev. 2010, 23, 23-26.
19. Kalliomaki, M., Kirjavainen, P., Eerola, E., Kero, P. et al., Distinct patterns of neonatal gut microflora in infants whom atopy was and was not developing. J. Allergy Clin. Immunol. 2001, 107, 129-134.
20. Yao, T. C., Chang, C. T., Hsu, Y. H., Huang, J. L., Probiotics for allergic diseases: realities and myths. Pediatr. Allergy Immunol. 2010, 21, 900-919.
21. Kalliomaki, M., Antoine, J. M., Herz, U., Rijkers, G. T. et al., Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J. Nutr. 2010, 140, 713S-721S.
22. Huurre, A., Laitinen, K., Rautava, S., Korkeamäki, M. et al., Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controled study. Clin. Exp. Allergy 2008, 38, 1342-1348.
23. Rautava, S., Kalliomaki, M., Isolauri, E., New therapeutic strategy for combating the increasing burden of allergic disease: probiotics-A Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Resarch Group report. J. Allergy Clin. Immunol. 2005, 116, 31-37.
24. Özdemir, O., Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin. Exp. Immunol. 2010, 160, 295-304.
25. Szajewska, H., Ruszczyński, M., Radzikowski, A., Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J. Pediatr. 2006, 149, 367-372.
26. Claesson, M. J., Cusack, S., O'Sullivan, O., Greene-Diniz, R. et al., Composition, variability and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. USA. 2010, 108, 4586-4591.
27. Candore, G., Caruso, C., Jirillo, E., Magrone, T. et al., Low grade inflamation as a common pathogenic denominator in age-related diseases: novel drug targets for anti-ageing strategies and succesfully ageing achievement. Curr. Pharma. Des. 2010, 16, 584-596.
28. Vallejo, A. N., Immunological hurdles of ageing: indispensable research on the human model. Ageing Res. Rev. 2011, 10, 315-318.
29. Baker, H. C., Tran, D. N., Thomas, L. V., Health benefits of probiotics for the elderly: a review. J. Foodserv. 2009, 20, 250-262.
30. Tiihonen, K., Ouwehand, A. C., Rautonen, N., Human intestinal microbiota and healthy ageing. Ageing Res. Rev. 2010, 9, 107-116.
31. Biagi, E., Nylund, L., Candela, M., Ostan, R. et al., Though ageing and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2011, 5, E10667.
32. Ouwehand, A. C., Lagström, H., Suomalainen, T., Salminen, S., Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann. Nutr. Metab. 2002, 46, 159-162.
33. Zaharoni, H., Rimon, E., Vardi, H., Fringer, M. et al., Probiotcs improve bowel movements in hospitalized elderly patients-the PROAGE study. J. Nutr. Healthy Ageing 2011, 15, 215-220.
34. Ibrahim, F., Ruvio, S., Granlund, L., Salminen, S. et al., Probiotics and immunosenescence: cheese as a carrier. FEMS Immunol. Med. Microbiol. 2010, 59, 53-59.
35. Takeda, K., Okumura, K., Effects of a fermented milk drink containing Lactobacillus casei strain shirota on the human NK-cell activity. J. Nutr. 2007, 137, 791S-793S.
36. Guillemard, E., Tondu, F., Lacoin, F., Schrezenmeir, J., Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Brit. J. Nutr. 2010, 103, 58-68.
37. Makino, S., Ikegami, S., Kume, A., Horiuchi, H. et al., Reducing the risk of infection in the elderly by dietary intake of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Brit. J. Nutr. 2010, 104, 998-1006.
38. Turchet, P., Laurenzano, M., Auboiron, S., Antoine, J. M., Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J. Nutr. Health Aging. 2003, 7, 75-77.
39. Strober, W., Fuss, I. J., Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterol. 2011, 140, 1756-1767.
40. Fuss, I. J., Heller, F., Boirivant, M., Leon, F. et al., Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 2004, 113, 1490-1497.
41. Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I. et al., The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31, 677-689.
42. Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L. et al., Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139, 485-498.
43. Atarashi, K., Tanoue, T., Shima, T., Imaoka, A. et al., Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331, 337-341.
44. Maloy, K., Powrie, F., Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011, 474, 298-306.
45. Gueimonde, M., Ouwehand, A., Huhtinen, H., Salminen, E. et al., Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J. Gastroenterol. 2007, 13, 3985-3989.
46. Sokol, H., Seksik, P., Furet, J. P., Firmesse, O. et al., Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 2009, 15, 1183-1189.
47. Pena, J. A., Rogers, A. B., Ge, Z. M., Ng, V. et al., Probiotic Lactobacillus spp. diminish Helicobacteri hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect. Immun. 2005, 73, 912-920.
48. Yan, F., Polk, D. B., Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem. 2002, 277, 50959-50965.
49. Reiff, C., Delday, M., Rucklidge, G., Reid, M. et al., Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm. Bowel Dis. 2009, 15, 1721-1736.
50. Donato, K. A., Gareau, M. G., Wang, Y. J. J., Sherman, P. M., Lactobacillus rhamnosus GG attenuates interferon-gamma and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signaling. Microbiology-SGM. 2010, 156, 3288-3297.
51. Hong, Y. S., Ahn, Y. T., Park, J. C., Lee, J. H. et al., (1)H NMR-based metabonomic assessment of probiotic effects in a colitis mouse mode. Arch. Pharma. Res. 2010, 33, 1091-1101.
52. Cary, V. A., Boullata, J., What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease? J. Clin. Nurs. 2010, 19, 904-916.
53. Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W. et al., Functional bowel disorders and functional abdominal pain. Gut. 1999, 45(Suppl 2), 43-47.
54. Parkes, G. C., Sanderson, J. D., Whelan, K., Treating irritable bowel syndrome with probiotics: the evidence (Symposium on "Dietary management of disease"). Proc. Nutr. Soc. 2010, 69, 187-194.
55. Petrovska, L., Hudspith, B. N., Okeke, I., Rayment, N. B. et al., Molecular characterization of mucosal enterobacteriaceae isolated from patients with inflammatory bowel disease. Gut. 2007, 56(Suppl 2), A118-A118.
56. ÓMahony, L., McCarthy, J., Kelly, P., Hurtley, G. et al., Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterol. 2005, 128, 541-551.
57. Zeng, J., Li, Y. Q., Zuo, X. L., Zhen, Y. B. et al., Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 2008, 28, 994-1002.
58. Rousseaux, C., Thuru, X., Gelot, A., Barnich, N. et al., Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 2007, 13, 35-37.
59. Hoveyda, N., Heneghan, C., Mahtani, K. R., Perera, R. et al., A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009, 9, 15.
60. Boden, S. R., Wesley-Burks, A., Anaphylaxis: a history with emphasis on food allergy. Immunol. Rev. 2011, 242, 247-257.
61. Guandalini, S., Newland, C., Differentiating food allergies from food intolerances. Curr. Gastroenterol. Rep. 2011, 13, 426-434.
62. Sanz, Y., Palma, G. D., Laparra, M., Unraveling the ties between celiac disease and intestinal microbiota. Int. Rev. Immunol. 2011, 30, 207-218.
63. Rancitelli, P., Hofman, A., Wesley-Burks, A., Vaccine approaches for food allergy. Curr. Top Microbiol. Immunol. 2011, 352, 55-69.
64. Helin, T., Haahtela, S., Haahtela, T., No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002, 57, 243-246.
65. Snel, J., Vissers, Y. M., Smit, B. A., Jongen, J. M. et al., Strain-specific immunomodulatory effect of Lactobacillus plantarum strains on birch-pollen-ellergic subjects out of season. Clin. Exp. Allergy. 2011, 41, 323-342.
66. Xiao, J. Z., Kondo, S., Yanagisawa, N., Miyaji, K. et al., Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit. Allergol. Int. 2007, 56, 67-75.
67. WHO. Report of a joint FAO/WHO Expert consultation. Human Vitamin and Mineral Requirements. 2001. FAO, Rome, Italy.
68. Díez-Gañan, L., Galán Labaca, I., León Domínguez, C. M., Zorrilla Torras, B., Encuesta de Nutrición Infantil de la Comunidad de Madrid. Consejería de Sanidad de la Comunidad de Madrid, Madrid 2008.
69. Agostoni, C., Braegger, C., Decsi, T., Kolacek, S. et al., ESPGHAN Committee on Nutrition. Breastfeeding: a commentary by the ESPGHAN Committee on Nutrition. J. Pediatric. Gastroenterol. Nutr. 2009, 49, 112-125.
70. Arboleya, S., Sánchez, B., Fernández, N., Solís, G. et al., Breast-milk lactobacilli and bifidobacteria: opportunities for the development of infant formulas. Agro. Food Industry Hi-Tech. 2011, 22, 24-26.
71. Fernández San Juan, P. M., Dietary habits and nutritional status of school aged children in Spain. Nutr Hosp. 2006, 21, 374-378.
72. Serra-Majem, L., Vitamin and mineral intakes in European children. Is food fortification needed? Public Health Nutr. 2001, 4, 101-107.
73. Serra-Majem, L., Ribas-Barba, L., Pérez-Rodrigo, C., Bartrina, J. A., Nutrient adequacy in Spanish children and adolescents. Br. J. Nutr. 2006, 96, 49-57.
74. Christensen, K., Doblhammer, G., Rau, R., Vaupel, J. W., Ageing populations: the challenges ahead. Lancet 2009, 374, 1196-1208.
75. Sanderson, W. C., Scherbov, S., Demography. remeasuring aging. Science. 2010, 329, 1287-1288.
76. Koehler, K. M., Garry, P. L., Nutrition and aging. Clin. Lab. Med. 1993, 13, 433-453.
77. Schlenker, E. D., Nutrición en el envejecimiento 2 ed. Mosby/Doyma Libros, Madrid 1994.
78. Aranceta, J., Serra-Majem, L., Pérez-Rodrigo, C., Llopis, J. et al., Vitamins in Spanish food patterns: the eVe study. Public Health Nutr. 2001, 4, 1317-1323.
79. Varela, G., Ortega, R. M., Nutrición en el anciano sano. Geriatrika, 1987, 3, 335-337.
80. Del Pozo, C., Cuadrado, C., Moreiras, O., Cambios con la edad en la ingesta dietética de personas de edad avanzada. Estudio Euronut-SENECA. Nutr. Hosp. 2003, 13, 348-352.
81. Rigaud, D., Angel, L. A., Cerf, M., Carduner, M. J. et al., Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsortion. Am. J. Clin. Nutr. 1994, 60, 775-781.
82. Chowers, Y., Sela, B. A., Holland, R., Fidder, H. et al., Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am. J. Gastroenterol. 2000, 95, 3498-3502.
83. Vagianos, K., Bector, S., Mc Conell, J., Bernstain, C. N., Nutrition assessment of patients with inflammatory bowel disease. JPEN. 2007, 31, 311-319.
84. Hebuterne, X., Piche, T., Apports en vitamins en pathologie digestive. Gastroenterol. Clin. Biol. 1999, 23, B106-B114.
85. Filipi, J., Al-Jaouni, R., Wiroth, J. B., Hébuterne, X. et al., Nutritional deficiencies in patients with Chron's disease in remission. Inflamm. Bowel Dis. 2006, 12, 185-191.
86. MacLean, C. H., Mojica, W. A., Newberry, S. J., Pencharz, J. et al., Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am. J. Clin. Nutr. 2005, 82, 11-19.
87. Turner, D., Zlotkin, S. H., Shah, P. S., Griffiths, A. M., Omega-3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst. Rev. 2007, CD006320.
88. Sundar, N., Crimmins, R., Swift, G., Clinical presentation and incidence of complications in patients with coeliac disease diagnosed by relative screening. Postgrad Med J. 2007, 83, 273-276.
89. Hallert, C., Grant, C., Grehn, S., Grännö, C. et al., Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years. Aliment. Pharmacol. Ther. 2002, 16, 1333-1339.
90. Murray, J. A., The widening spectrum of celiac disease. Am J Clin Nutr. 1999, 69, 354-363.
91. Fasano, A., Catassi, C., Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterol. 2001, 120, 636-651.